Interleukin-18: Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome
- 30 September 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 182 (1) , 135-143
- https://doi.org/10.1016/j.atherosclerosis.2005.02.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Inflammatory imbalance between IL‐10 and TNFα in unstable angina potential plaque stabilizing effects of IL‐10European Journal of Clinical Investigation, 2002
- Immune Mechanisms in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Interleukin-18 Regulates Both Th1 and Th2 ResponsesAnnual Review of Immunology, 2001
- IL‐10 inhibits LPS‐induced human monocyte tissue factor expression in whole bloodBritish Journal of Haematology, 1998
- Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Journal of Clinical Investigation, 1998
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.Journal of Clinical Investigation, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human MonocytesJournal of Biological Chemistry, 1995
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967